(Total Views: 222)
Posted On: 03/02/2017 3:39:43 PM
Post# of 72440
No, he's still with Dana Farber. He assisted with the P1 trial, I'd have to look but he may have been one of the lead investigators, or THE lead. In the very early stages we also had Dr. Frei
https://en.wikipedia.org/wiki/Emil_Frei
Actually I just noticed they took him off the Cellceutix web site under management, there used to be a "In memorial" or something like that for him.
Here's one of his comments...
“What Cellceutix is doing with Kevetrin™ can lead to a groundbreaking moment in the world of oncology,” commented Cellceutix Scientific Advisor Dr. Emil Frei III, M.D. “In my career, including my tenure as Chief of Medicine at National Cancer Institute, I have seen countless companies throughout the world striving to bridge the gap between damaged or mutated p53 and carcinomas with little to no success. p53 can hold a vital key to the next generation of chemotherapy. Cellceutix’s discovery of Kevetrin™, which has been shown to reactivate p53 in a non-genotoxic manner, is a very promising advance in the fight against cancer.”
http://www.cellceutix.com/press-release-2/201...er?rq=frei
He was one of THE BEST cancer researchers ahead of his time.
Realizing through my DD when I first found Cellceutix who "believed" in it is why I've stuck with it. Trading along the way of course, but definitely will be seeing it through.
Dr. Shapiro is also one of the most recognized names as well.
IMO
https://en.wikipedia.org/wiki/Emil_Frei
Actually I just noticed they took him off the Cellceutix web site under management, there used to be a "In memorial" or something like that for him.
Here's one of his comments...
“What Cellceutix is doing with Kevetrin™ can lead to a groundbreaking moment in the world of oncology,” commented Cellceutix Scientific Advisor Dr. Emil Frei III, M.D. “In my career, including my tenure as Chief of Medicine at National Cancer Institute, I have seen countless companies throughout the world striving to bridge the gap between damaged or mutated p53 and carcinomas with little to no success. p53 can hold a vital key to the next generation of chemotherapy. Cellceutix’s discovery of Kevetrin™, which has been shown to reactivate p53 in a non-genotoxic manner, is a very promising advance in the fight against cancer.”
http://www.cellceutix.com/press-release-2/201...er?rq=frei
He was one of THE BEST cancer researchers ahead of his time.
Realizing through my DD when I first found Cellceutix who "believed" in it is why I've stuck with it. Trading along the way of course, but definitely will be seeing it through.
Dr. Shapiro is also one of the most recognized names as well.
IMO
(1)
(0)Scroll down for more posts ▼
